Jusmiral Holdings reduces stake in Cohance Lifesciences to repay debt

Jusmiral Holdings Limited, a promoter of Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited), executed an on-market sale of 34.15m equity shares on September 18, 2025. This transaction reduced Jusmiral Holdings' stake from 33.08% to 24.15%.

The proceeds from this sale are primarily intended for part payment of borrowings under a notes purchase agreement dated May 29, 2024. Jusmiral Holdings clarified that it had not directly pledged any equity shares of Cohance Lifesciences. However, Jusmiral Midco Limited, a wholly-owned subsidiary of Jusmiral Holdings, had created a pledge on its entire shareholding in Jusmiral Holdings Limited.

These disclosures regarding the release of encumbrance were made in accordance with Regulation 31(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The shareholding information for Berhyanda Limited, another promoter, remains unchanged at 33.34%, with no pledges on its Cohance Lifesciences equity shares.